Skip to content

Medicine Man Technologies, Inc.: filings

Every Medicine Man Technologies, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 38 filings, each linked to its SEC index.

Filing record ends 2024-03-27

The latest filing in this captured record is a 10-K filed 2024-03-27. No later filing is in the SEC companyfacts record captured on 2026-09-22. Medicine Man Technologies, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2024-03-27fiscal FY 2023571140001558370-24-004104
10-Q2023-11-14fiscal Q3 2023551510001558370-23-019071
10-Q2023-08-10fiscal Q2 2023551530001558370-23-014456
10-Q2023-05-11fiscal Q1 2023521070001558370-23-009230
10-K2023-03-29fiscal FY 2022581160001558370-23-004949
10-Q2022-11-10fiscal Q3 2022541450001558370-22-017270
10-Q2022-08-11fiscal Q2 2022541500001683168-22-005557
10-Q/A2022-05-27fiscal Q1 2022501030001683168-22-004067
10-Q2022-05-16fiscal Q1 2022501030001683168-22-003684
10-K2022-03-31fiscal FY 2021571160001683168-22-002216
10-Q2021-11-15fiscal Q3 2021481340001683168-21-005695
10-Q2021-08-16fiscal Q2 2021461280001683168-21-003724
10-Q2021-05-13fiscal Q1 202144900001683168-21-001967
10-K2021-03-31fiscal FY 2020501010001683168-21-001161
10-Q2020-11-16fiscal Q3 2020421120001683168-20-003969
10-Q2020-08-14fiscal Q2 2020421140001683168-20-002720
10-Q2020-05-14fiscal Q1 202043900001683168-20-001565
10-K2020-03-30fiscal FY 201947950001683168-20-001021
10-Q2019-11-12fiscal Q3 2019401090001683168-19-003540
10-Q2019-08-14fiscal Q2 2019401090001683168-19-002641
10-Q2019-05-20fiscal Q1 201940840001683168-19-001646
10-K2019-04-16fiscal FY 201846920001683168-19-001081
10-Q2018-11-08fiscal Q3 201837960001683168-18-003304
10-Q2018-08-08fiscal Q2 2018391020001683168-18-002213
10-Q2018-05-03fiscal Q1 201837750001683168-18-001168
10-K2018-03-27fiscal FY 201739800001683168-18-000768
10-Q2017-11-09fiscal Q3 201737960001683168-17-002881
10-Q2017-08-17fiscal Q2 201733880001683168-17-002170
10-Q/A2017-05-18fiscal Q1 201732660001683168-17-001328
10-Q/A2017-05-16fiscal Q1 201732660001683168-17-001294
10-Q2017-05-16fiscal Q1 201732660001683168-17-001290
10-K2017-04-17fiscal FY 201633680001683168-17-000950
10-Q2016-11-14fiscal Q3 201631810001683168-16-000635
10-Q/A2016-08-19fiscal Q2 201631840001019687-16-007310
10-Q2016-08-15fiscal Q2 201631840001019687-16-007237
10-Q2016-05-16fiscal Q1 201633680001019687-16-006286
10-K2016-04-14fiscal FY 201534700001019687-16-005856
10-Q2015-11-12fiscal Q3 201524650001019687-15-004016

Inspect the source

Entity
Medicine Man Technologies, Inc. / CIK 0001622879
Captured
SEC response SHA-256
1261bd7a9caa81b103d72d0d0ab2acc4054c1fb2aa448834ecbc9bb252b5bd72

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001622879.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))